References
- Centers for Disease Control and Prevention. U.S. Overdose deaths in 2021 increased half as much as in 2020 - but are still up 15%. Published 2022 May 11 [ accessed 2022 May 16]. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/202205.htm.
- Missouri Department of Health & Senior Services. Quarterly data request DHSS [ Unpublished Raw Data]. Published online 2020-2021.
- Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry. 2021;34:344–50. doi:10.1097/YCO.0000000000000717.
- Substance Abuse and Mental Health Services Administration. Treatment of stimulant use disorders. Substance Abuse and Mental Health Services Administration; 2020 [accessed 2022 May 16]. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwixqLXvneT3AhURnnIEHbyzDHAQFnoECAgQAw&url=https%3A%2F%2Fstore.samhsa.gov%2Fsites%2Fdefault%2Ffiles%2FSAMHSA_Digital_Download%2FPEP20-06-01-001_508.pdf&usg=AOvVaw02bNU_kP21Sab0fwVRim6a.
- Stitzer ML, Petry N. Contingency management for treatment of substance abuse. Annu Rev Clin Psychol. 2006;2:411–34. doi:10.1146/annurev.clinpsy.2.022305.095219.
- Benishek LA, Dugosh KL, Kirby KC, Matejkowski J, Clements NT, Seymour BL, Festinger DS, et al. Prize-Based contingency management for the treatment of substance abusers: a meta-analysis. Addict Abingdon Engl. 2014;109:1426–36. doi:10.1111/add.12589.
- Pfund RA, Ginley MK, Rash CJ, Zajac K. Contingency management for treatment attendance: a meta-analysis. J Subst Abuse Treat. 2022;133:108556. doi:10.1016/j.jsat.2021.108556.
- Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addict Abingdon Engl. 2006;101:1546–60. doi:10.1111/j.1360-0443.2006.01581.x.
- Green TC, Park JN, Gilbert M, McKenzie M, Struth E, Lucas R, Clarke W, Sherman SG, et al. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. Int J Drug Policy. 2020;77:102661.
- Reed MK, Roth AM, Tabb LP, Groves AK, Lankenau SE. “I probably got a minute”: perceptions of fentanyl test strip use among people who use stimulants. Int J Drug Policy. 2021;92:103147. doi:10.1016/j.drugpo.2021.103147.
- Krieger MS, Goedel WC, Buxton JA, Lysyshyn M, Bernstein E, Sherman SG, Rich JD, Hadland SE, Green TC, Marshall BDL, et al. Use of rapid fentanyl test strips among young adults who use drugs. Int J Drug Policy. 2018;61:52–58.
- Weicker NP, Owczarzak J, Urquhart G, Park JN, Rouhani S, Ling R, Morris M, Sherman SG, et al. Agency in the fentanyl era: exploring the utility of fentanyl test strips in an opaque drug market. Int J Drug Policy. 2020;84:102900.
- Substance Abuse and Mental Health Services Administration. 2020. Report to Congress on the State Opioid Response Grants. Published online 2020 accessed 2021 Dec 7. https://www.samhsa.gov/sites/default/files/grants/pdf/other/samhsa-sor-report.pdf.
- 42 U.S. Code § 1320a–7b - criminal penalties for acts involving federal health care programs. LII/Legal Information Institute; [accessed 2022 Jan 12]. https://www.law.cornell.edu/uscode/text/42/1320a-7b.
- Goldman JE, Waye KM, Periera KA, Krieger MS, Yedinak JL, Marshall BDL. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study. Harm Reduct J. 2019;16:3. doi:10.1186/s12954-018-0276-0.
- Peiper NC, Clarke SD, Vincent LB, Ciccarone D, Kral AH, Zibbell JE. Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the Southeastern United States. Int J Drug Policy. 2019;63:122–28. doi:10.1016/j.drugpo.2018.08.007.
- Marsh JC, Amaro H, Kong Y, Khachikian T, Guerrero E. Gender disparities in access and retention in outpatient methadone treatment for opioid use disorder in low-income urban communities. J Subst Abuse Treat. 2021;127:108399. doi:10.1016/j.jsat.2021.108399.
- Acevedo A, Harvey N, Kamanu M, Tendulkar S, Fleary S. Barriers, facilitators, and disparities in retention for adolescents in treatment for substance use disorders: a qualitative study with treatment providers. Subst Abuse Treat Prev Policy. 2020;15:1–13. doi:10.1186/s13011-020-00284-4.
- Arndt S, Acion L, White K. How the states stack up: disparities in substance abuse outpatient treatment completion rates for minorities. Drug Alcohol Depend. 2013;132:547–54. doi:10.1016/j.drugalcdep.2013.03.015.
- Winograd RP, Rudder T, Stringfellow EJ, et al. The case for a medication first approach to the treatment of opioid use disorder. Am J Drug Alcohol Abuse. Published online 2019. doi: 10.1080/00952990.2019.1605372.
- Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addict Abingdon Engl. 2006;101:192–203. doi:10.1111/j.1360-0443.2006.01311.x.
- Petry NM, Tedford J, Austin M, Nich C, Carroll KM, Rounsaville BJ. Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom? Addict Abingdon Engl. 2004;99:349–60. doi:10.1111/j.1360-0443.2003.00642.x.
- Petry NM Contingency management for substance abuse treatment: a guide to implementing this evidence-based practice. Routledge & CRC Press. Published 2013 [accessed 2022 Jan 12. https://www.routledge.com/Contingency-Management-for-Substance-Abuse-Treatment-A-Guide-to-Implementing/Petry/p/book/9780415882897.
- Missouri Overdose Information. MIMH addiction science. [Published 2022 Apr [accessed 2022 May 16]. https://www.mimhaddisci.org/missouri-overdose-data.
- Cano M, Sparks CS. Drug overdose mortality by race/ethnicity across US-born and immigrant populations. Drug Alcohol Depend. 2022;232:109309. doi:10.1016/j.drugalcdep.2022.109309.
- Park JN, Rouhani S, Beletsky L, Vincent L, Saloner B, Sherman SG. Situating the continuum of overdose risk in the social determinants of health: a new conceptual framework. Milbank Q. 2020;98:700–46. doi:10.1111/1468-0009.12470.
- Castro FG, Barrera M, Marsiglia FF. Cultural adaptation of empirically validated therapies for treating drug dependence: international considerations. In: el-Guebaly N, G Carrà, M Galanter, A Baldacchino, editors. Textbook of addiction treatment: international perspectives. Springer International Publishing; 2021. p. 519–34. doi: 10.1007/978-3-030-36391-8_36.
- Unlawful possession of drug paraphernalia — penalty. 2017. 579.074. [accessed 2021 Dec 7]. https://revisor.mo.gov/main/OneSection.aspx?section=579.074&bid=30232.